Observational studyOrphanet journal of rare diseases2022

An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.

Duncan Richards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.